Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 281, Issue 26, Pages 17882-17889Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M601302200
Keywords
-
Categories
Funding
- NIEHS NIH HHS [ES 09859, P30 ES005022, ES 09106] Funding Source: Medline
Ask authors/readers for more resources
It is a long-standing observation that inflammatory responses and infections decrease drug metabolism capacity in human and experimental animals. Cytochrome P-450 3A4 cyp304 is responsible for the metabolism of over 50% of current prescription drugs, and cyp3a4 expression is transcriptionally regulated by pregnane X receptor (PXR), which is a ligand-dependent transcription factor. In this study, we report that NF-kappa B activation by lipopolysaccharide and tumor necrosis factor-alpha plays a pivotal role in the suppression of cyp3a4 through interactions of NF-kappa B with the PXR . retinoid X receptor (RXR) complex. Inhibition of NF-kappa B by NF-kappa B-specific suppressor SRI kappa B alpha reversed the suppressive effects of lipopolysaccharide and tumor necrosis factor-alpha. Furthermore, we showed that NF-kappa B p65 disrupted the association of the PXR . RXR alpha complex with DNA sequences as determined by electrophoretic mobility shift assay and chromatin immunoprecipitation assays. NF-kappa B p65 directly interacted with the DNA-binding domain of RXR alpha and may prevent its binding to the consensus DNA sequences, thus inhibiting the transactivation by the PXR . RXR alpha complex. This mechanism of suppression by NF-kappa B activation may be extended to other nuclear receptor-regulated systems where RXR alpha is a dimerization partner.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available